Mometasone furoate in the treatment of mild, moderate, or severe persistent allergic rhinitis: a non-inferiority study (PUMA)

Antila, Martti; Castro, Fábio Morato; Sano, Flávio; Machado, Adelmir de Souza; Fernandes, Fátima Rodrigues; Filho, Nelson Augusto Rosário; Stelmach, Rafaël

doi:10.1016/j.bjorl.2015.11.009

Cited by 1 publication

(1 citation statement)

References 31 publications

(35 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A first generation corticosteroid, dexamethasone, is no longer preferred due to its side effects ( 452 ). The second generation corticosteroids, including beclomethasone dipropionate (aerosol) ( 453 - 460 ), budesonide (aqueous) ( 461 - 463 ), ciclesonide (aqueous or aerosol) ( 464 - 466 ), flunisolide (aqueous), fluticasone furoate (aqueous) ( 467 - 470 ), fluticasone propionate (aqueous) ( 471 - 474 ), triamcinolone acetonide (aqueous) ( 475 - 476 ) and mometasone furotate (aqueous) ( 466 , 477 - 482 ) have been used in nasal spray preparations until today.…”

Section: Treatment Of Allergic Rhinitismentioning

confidence: 99%

Turkish Guidelines for Diagnosis and Treatment of Allergic Rhinitis (ART)

Ecevit¹,

Özcan²,

Can³

et al. 2021

TAO

View full text Add to dashboard Cite

Object: To prepare a national guideline for Otorhinolaryngologist who treat allergic rhinitis patients. Methods: The study was conducted by three authors, namely the writing support team. The support team made the study plan, determined the writing instructions, chose the subgroups including the advisory committee, the advisors for authors and the authors. A workshop was organized at the very beginning to explain the details of the study to the team. Advisors took the chance to meet their coworkers in their subgroups and determined the main headings and subheadings of the guideline, together with the authors. After key words were determined by the authors, literature search was done in various databases. The authors keep in touch with the advisors and the advisors with the advisory committee and the support group at every stage of the study. National and International published articles as well as the abstracts of unpublished studies, imperatively presented in National Congresses, were included in this guideline. Only Guideline and meta-analyses published in last seven years (2013-2017) and randomized controlled studies published in last two years (2015-2017) were included. After all work was completed by the subgroups, support team brought all work together and edited the article. Results: A detailed guideline about all aspects of allergic rhinitis was created. Conclusion: The authors believe that this guideline will enable a compact and up-to-date information on allergic rhinitis to healthcare professionals. This guideline is the first in the field of Otolaryngology in Turkey. It should be updated at regular intervals.

show abstract